• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T 细胞中的线粒体功能障碍:以炎症性肠病为例。

Mitochondrial dysfunctions in T cells: focus on inflammatory bowel disease.

机构信息

Research Institute of Aging and Metabolism, Kyungpook National University, Daegu, Republic of Korea.

Department of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Chilgok Hospital, Daegu, Republic of Korea.

出版信息

Front Immunol. 2023 Sep 22;14:1219422. doi: 10.3389/fimmu.2023.1219422. eCollection 2023.

DOI:10.3389/fimmu.2023.1219422
PMID:37809060
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10556505/
Abstract

Mitochondria has emerged as a critical ruler of metabolic reprogramming in immune responses and inflammation. In the context of colitogenic T cells and IBD, there has been increasing research interest in the metabolic pathways of glycolysis, pyruvate oxidation, and glutaminolysis. These pathways have been shown to play a crucial role in the metabolic reprogramming of colitogenic T cells, leading to increased inflammatory cytokine production and tissue damage. In addition to metabolic reprogramming, mitochondrial dysfunction has also been implicated in the pathogenesis of IBD. Studies have shown that colitogenic T cells exhibit impaired mitochondrial respiration, elevated levels of mROS, alterations in calcium homeostasis, impaired mitochondrial biogenesis, and aberrant mitochondria-associated membrane formation. Here, we discuss our current knowledge of the metabolic reprogramming and mitochondrial dysfunctions in colitogenic T cells, as well as the potential therapeutic applications for treating IBD with evidence from animal experiments.

摘要

线粒体已成为免疫反应和炎症中代谢重编程的关键调节者。在致结肠炎 T 细胞和 IBD 的背景下,人们对糖酵解、丙酮酸氧化和谷氨酰胺分解代谢途径的代谢途径越来越感兴趣。这些途径在致结肠炎 T 细胞的代谢重编程中发挥着关键作用,导致炎症细胞因子产生增加和组织损伤。除了代谢重编程,线粒体功能障碍也与 IBD 的发病机制有关。研究表明,致结肠炎 T 细胞表现出线粒体呼吸受损、mROS 水平升高、钙稳态改变、线粒体生物发生受损以及异常的线粒体相关膜形成。在这里,我们讨论了我们目前对致结肠炎 T 细胞代谢重编程和线粒体功能障碍的了解,以及从动物实验中获得的用证据治疗 IBD 的潜在治疗应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10556505/38427ea5bfe1/fimmu-14-1219422-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10556505/7f4036a4c171/fimmu-14-1219422-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10556505/cd1a705672a0/fimmu-14-1219422-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10556505/9a27b8b6b7c6/fimmu-14-1219422-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10556505/d4fe78908148/fimmu-14-1219422-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10556505/629495200213/fimmu-14-1219422-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10556505/a354fe07d1db/fimmu-14-1219422-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10556505/38427ea5bfe1/fimmu-14-1219422-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10556505/7f4036a4c171/fimmu-14-1219422-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10556505/cd1a705672a0/fimmu-14-1219422-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10556505/9a27b8b6b7c6/fimmu-14-1219422-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10556505/d4fe78908148/fimmu-14-1219422-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10556505/629495200213/fimmu-14-1219422-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10556505/a354fe07d1db/fimmu-14-1219422-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10556505/38427ea5bfe1/fimmu-14-1219422-g007.jpg

相似文献

1
Mitochondrial dysfunctions in T cells: focus on inflammatory bowel disease.T 细胞中的线粒体功能障碍:以炎症性肠病为例。
Front Immunol. 2023 Sep 22;14:1219422. doi: 10.3389/fimmu.2023.1219422. eCollection 2023.
2
The Role of Mitochondria Dysfunction in Inflammatory Bowel Diseases and Colorectal Cancer.线粒体功能障碍在炎症性肠病和结直肠癌中的作用。
Int J Mol Sci. 2021 Oct 28;22(21):11673. doi: 10.3390/ijms222111673.
3
Mitochondrial biogenesis: pharmacological approaches.线粒体生物合成:药理学方法。
Curr Pharm Des. 2014;20(35):5507-9. doi: 10.2174/138161282035140911142118.
4
The role of cholesterol and mitochondrial bioenergetics in activation of the inflammasome in IBD.胆固醇和线粒体生物能学在 IBD 中炎症小体激活中的作用。
Front Immunol. 2022 Nov 18;13:1028953. doi: 10.3389/fimmu.2022.1028953. eCollection 2022.
5
Macrophage immunometabolism in inflammatory bowel diseases: From pathogenesis to therapy.巨噬细胞免疫代谢在炎症性肠病中的作用:从发病机制到治疗。
Pharmacol Ther. 2022 Oct;238:108176. doi: 10.1016/j.pharmthera.2022.108176. Epub 2022 Mar 26.
6
Role of Energy Metabolism and Mitochondrial Function in Inflammatory Bowel Disease.能量代谢和线粒体功能在炎症性肠病中的作用。
Inflamm Bowel Dis. 2022 Sep 1;28(9):1443-1450. doi: 10.1093/ibd/izac024.
7
Immunometabolism and mitochondria in inflammatory bowel disease: a role for therapeutic intervention?免疫代谢和炎症性肠病中的线粒体:治疗干预的作用?
Dis Model Mech. 2024 Oct 1;17(10). doi: 10.1242/dmm.050895. Epub 2024 Oct 17.
8
Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.稳态(IL-7)和效应(IL-17)细胞因子作为炎症性肠病最佳治疗策略中不同但互补的靶点。
Curr Opin Gastroenterol. 2009 Jul;25(4):306-13. doi: 10.1097/MOG.0b013e32832bc627.
9
Targeting Immune Cell Metabolism in the Treatment of Inflammatory Bowel Disease.靶向免疫细胞代谢治疗炎症性肠病。
Inflamm Bowel Dis. 2021 Oct 18;27(10):1684-1693. doi: 10.1093/ibd/izab024.
10
Metabolic reprogramming as a key regulator in the pathogenesis of rheumatoid arthritis.代谢重编程作为类风湿关节炎发病机制中的关键调节因子。
Inflamm Res. 2020 Nov;69(11):1087-1101. doi: 10.1007/s00011-020-01391-5. Epub 2020 Aug 14.

引用本文的文献

1
CRIF1 gene therapy ameliorates inflammatory bowel disease by suppressing TH17 cells and fibrosis through mitochondrial function regulation.CRIF1基因疗法通过调节线粒体功能抑制辅助性T细胞17(TH17)和纤维化,从而改善炎症性肠病。
Front Immunol. 2025 Jul 31;16:1618012. doi: 10.3389/fimmu.2025.1618012. eCollection 2025.
2
Immunometabolism of Tregs: mechanisms, adaptability, and therapeutic implications in diseases.调节性T细胞的免疫代谢:疾病中的机制、适应性及治疗意义
Front Immunol. 2025 Jan 23;16:1536020. doi: 10.3389/fimmu.2025.1536020. eCollection 2025.
3
Copper-luteolin nanocomplexes for Mediating multifaceted regulation of oxidative stress, intestinal barrier, and gut microbiota in inflammatory bowel disease.

本文引用的文献

1
Animal models of inflammatory bowel disease: novel experiments for revealing pathogenesis of colitis, fibrosis, and colitis-associated colon cancer.炎症性肠病的动物模型:揭示结肠炎、纤维化和结肠炎相关结肠癌发病机制的新实验
Intest Res. 2023 Jul;21(3):295-305. doi: 10.5217/ir.2023.00029. Epub 2023 May 31.
2
Pyruvate dehydrogenase fuels a critical citrate pool that is essential for Th17 cell effector functions.丙酮酸脱氢酶为一个关键的柠檬酸池提供能量,该柠檬酸池对于辅助性T细胞17(Th17)细胞的效应功能至关重要。
Cell Rep. 2023 Mar 28;42(3):112153. doi: 10.1016/j.celrep.2023.112153. Epub 2023 Feb 26.
3
Inhibition of Pyruvate Dehydrogenase Kinase 4 in CD4 T Cells Ameliorates Intestinal Inflammation.
用于介导炎症性肠病中氧化应激、肠道屏障和肠道微生物群多方面调节的铜-木犀草素纳米复合物
Bioact Mater. 2024 Dec 11;46:118-133. doi: 10.1016/j.bioactmat.2024.12.004. eCollection 2025 Apr.
4
The sedoheptulose kinase CARKL controls T-cell cytokine outputs and migration by promoting metabolic reprogramming.景天庚酮糖激酶CARKL通过促进代谢重编程来控制T细胞细胞因子的分泌和迁移。
Discov Immunol. 2024 Nov 19;3(1):kyae016. doi: 10.1093/discim/kyae016. eCollection 2024.
5
Metabolic regulation of the immune system in health and diseases: mechanisms and interventions.免疫系统的代谢调控在健康和疾病中的作用:机制与干预措施。
Signal Transduct Target Ther. 2024 Oct 9;9(1):268. doi: 10.1038/s41392-024-01954-6.
6
Exploring the immunometabolic potential of Danggui Buxue Decoction for the treatment of IBD-related colorectal cancer.探索当归补血汤治疗IBD相关结直肠癌的免疫代谢潜力。
Chin Med. 2024 Aug 29;19(1):117. doi: 10.1186/s13020-024-00978-y.
7
Mitochondrial function and gastrointestinal diseases.线粒体功能与胃肠道疾病。
Nat Rev Gastroenterol Hepatol. 2024 Aug;21(8):537-555. doi: 10.1038/s41575-024-00931-2. Epub 2024 May 13.
8
Polyphenols: immunonutrients tipping the balance of immunometabolism in chronic diseases.多酚:免疫营养素在慢性病中改变免疫代谢平衡。
Front Immunol. 2024 Mar 15;15:1360065. doi: 10.3389/fimmu.2024.1360065. eCollection 2024.
9
Immunological profile of lactylation-related genes in Crohn's disease: a comprehensive analysis based on bulk and single-cell RNA sequencing data.乳酰化相关基因在克罗恩病中的免疫特征:基于批量和单细胞 RNA 测序数据的综合分析。
J Transl Med. 2024 Mar 23;22(1):300. doi: 10.1186/s12967-024-05092-z.
10
Mitochondria: the gatekeepers between metabolism and immunity.线粒体:新陈代谢与免疫之间的守门人。
Front Immunol. 2024 Feb 23;15:1334006. doi: 10.3389/fimmu.2024.1334006. eCollection 2024.
抑制 CD4 T 细胞中的丙酮酸脱氢酶激酶 4 可改善肠道炎症。
Cell Mol Gastroenterol Hepatol. 2023;15(2):439-461. doi: 10.1016/j.jcmgh.2022.09.016. Epub 2022 Oct 10.
4
Carbon source availability drives nutrient utilization in CD8 T cells.碳源供应决定 CD8 T 细胞的营养物质利用。
Cell Metab. 2022 Sep 6;34(9):1298-1311.e6. doi: 10.1016/j.cmet.2022.07.012. Epub 2022 Aug 17.
5
Refining the Role of Pyruvate Dehydrogenase Kinases in Glioblastoma Development.优化丙酮酸脱氢酶激酶在胶质母细胞瘤发展中的作用
Cancers (Basel). 2022 Aug 2;14(15):3769. doi: 10.3390/cancers14153769.
6
Store-operated calcium entry controls innate and adaptive immune cell function in inflammatory bowel disease.钙库操纵性钙内流调控炎症性肠病中固有和适应性免疫细胞功能。
EMBO Mol Med. 2022 Sep 7;14(9):e15687. doi: 10.15252/emmm.202215687. Epub 2022 Aug 2.
7
The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming.葡萄糖转运蛋白 GLUT3 通过糖酵解-表观遗传重编程来控制辅助性 T 细胞 17 型细胞的反应。
Cell Metab. 2022 Apr 5;34(4):516-532.e11. doi: 10.1016/j.cmet.2022.02.015. Epub 2022 Mar 21.
8
Metabolism Characteristics of Th17 and Regulatory T Cells in Autoimmune Diseases.自身免疫性疾病中 Th17 和调节性 T 细胞的代谢特征。
Front Immunol. 2022 Feb 25;13:828191. doi: 10.3389/fimmu.2022.828191. eCollection 2022.
9
Defects in aminoacyl-tRNA synthetase cause partial B and T cell immunodeficiency.氨基酸酰-tRNA 合成酶缺陷导致部分 B 和 T 细胞免疫缺陷。
Cell Mol Life Sci. 2022 Jan 23;79(2):87. doi: 10.1007/s00018-021-04122-z.
10
The Role of Innate and Adaptive Immune Cells in the Pathogenesis and Development of the Inflammatory Response in Ulcerative Colitis.先天性和适应性免疫细胞在溃疡性结肠炎炎症反应的发病机制及发展中的作用
J Clin Med. 2022 Jan 13;11(2):400. doi: 10.3390/jcm11020400.